Tags

Type your tag names separated by a space and hit enter

[Clinical application of percutaneous endoscopic gastrostomy/jejunostomy in critically ill patients].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Jun; 30(3):253-6.ZY

Abstract

OBJECTIVE

To explore the clinical value of percutaneous endoscopic gastrostomy/jejunostomy (PEG/J) in critically ill patients.

METHODS

We retrospectively analysed the clinical data of 30 critically ill patients who received PEG/J in our hospital. The indications, key operation procedures, peri-operative preparation, complications, and efficacy were recorded.

RESULTS

Twenty-nine critically ill patients successfully received PEG/J. The mean operation time of PEG and PEJ were (7.5 +/- 2.5) min and (12.5 +/- 8.2) min, respectively, and the duration of tube functioning was (230 +/- 159) d; no procedure-related complications and serious complications were observed. Complications included local soft tissue infection (n = 1), J-tube dislodgment (n = 1), and obstruction of jejunal tube (n = 2). The serum levels of albumin and pre-albumin increased 4 weeks after operation; however, no significant difference was observed.

CONCLUSION

PEG/J is an effective, micro-invasive, safe, and convenient approach to establish a long-term gastrointestinal nutrition route for critically ill patients.

Authors+Show Affiliations

Department of General Surgery, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

chi

PubMed ID

18686600

Citation

Kang, Wei-Ming, et al. "[Clinical Application of Percutaneous Endoscopic Gastrostomy/jejunostomy in Critically Ill Patients]." Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae, vol. 30, no. 3, 2008, pp. 253-6.
Kang WM, Yu JC, Ma ZQ, et al. [Clinical application of percutaneous endoscopic gastrostomy/jejunostomy in critically ill patients]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008;30(3):253-6.
Kang, W. M., Yu, J. C., Ma, Z. Q., & Liu, X. H. (2008). [Clinical application of percutaneous endoscopic gastrostomy/jejunostomy in critically ill patients]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae, 30(3), 253-6.
Kang WM, et al. [Clinical Application of Percutaneous Endoscopic Gastrostomy/jejunostomy in Critically Ill Patients]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008;30(3):253-6. PubMed PMID: 18686600.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical application of percutaneous endoscopic gastrostomy/jejunostomy in critically ill patients]. AU - Kang,Wei-Ming, AU - Yu,Jian-Chun, AU - Ma,Zhi-Qiang, AU - Liu,Xiao-Hong, PY - 2008/8/9/pubmed PY - 2010/5/29/medline PY - 2008/8/9/entrez SP - 253 EP - 6 JF - Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae JO - Zhongguo Yi Xue Ke Xue Yuan Xue Bao VL - 30 IS - 3 N2 - OBJECTIVE: To explore the clinical value of percutaneous endoscopic gastrostomy/jejunostomy (PEG/J) in critically ill patients. METHODS: We retrospectively analysed the clinical data of 30 critically ill patients who received PEG/J in our hospital. The indications, key operation procedures, peri-operative preparation, complications, and efficacy were recorded. RESULTS: Twenty-nine critically ill patients successfully received PEG/J. The mean operation time of PEG and PEJ were (7.5 +/- 2.5) min and (12.5 +/- 8.2) min, respectively, and the duration of tube functioning was (230 +/- 159) d; no procedure-related complications and serious complications were observed. Complications included local soft tissue infection (n = 1), J-tube dislodgment (n = 1), and obstruction of jejunal tube (n = 2). The serum levels of albumin and pre-albumin increased 4 weeks after operation; however, no significant difference was observed. CONCLUSION: PEG/J is an effective, micro-invasive, safe, and convenient approach to establish a long-term gastrointestinal nutrition route for critically ill patients. SN - 1000-503X UR - https://www.unboundmedicine.com/medline/citation/18686600/[Clinical_application_of_percutaneous_endoscopic_gastrostomy/jejunostomy_in_critically_ill_patients]_ L2 - https://antibodies.cancer.gov/detail/CPTC-TTR-1 DB - PRIME DP - Unbound Medicine ER -